Back to search

Article

Insights from a double-blind, randomized, direct-to-participant intervention trial for Long COVID

2026-08-22

Abstract excerpt

<h4>Background: </h4> Long COVID affects an estimated 400 million people worldwide, and is associated with low quality of life. Nearly all completed Long COVID clinical trials reported no benefit, and most required participants to travel to study sites. This requirement systematically excludes severely affected patients. Because there are numerous candidate therapeutics with established safety profiles and regulat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d2dc523-a27e-529a-b572-be3983617e21
DOI
10.64898/2026.08.19.26360832
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Insights from a double-blind, randomized, direct-to-participant intervention trial for Long COVIDDOI 10.64898/2026.08.19.26360832
An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC TrialSemantic proximity
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocolSemantic proximity
Demographic Representation of a Decentralized Long COVID Trial: A Comparison with the 2023 National Health Interview SurveySemantic proximity
Development process of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE (DosE FIndiNg Extensions) studySemantic proximity
A Novel Feasibility Study Design Enabling Informative Clinical Trials in Low Resource Settings: the Pop-Up Prevalence study with Private Ethics (PUPPE)Semantic proximity
A Core Outcome Set for Clinical Trials on Post COVID-19 Condition: 'What', 'When' and 'How' to MeasureSemantic proximity
Forming a Consensus Opinion on Long COVID Support Mechanisms and Interventions Using a Modified Delphi ApproachSemantic proximity
Impact of SARS-Cov-2 on Clinical Trial Unit Staff: The EPIC Observational StudySemantic proximity
Effects of Specialized Pro-Resolving Mediators and Telerehabilitation on Fatigue, Dyspnea, and Quality of Life in Post‑COVID‑19 Condition: The ARACOV-02 Randomized Controlled Trial.Semantic proximity
Core Outcome Set for Research and Clinical Practice in Post COVID-19 Condition (Long COVID): An International Delphi Consensus Study ‘PC-COS’Semantic proximity
Challenges and Lessons Learned from COVID-19 Trials – Should We be Doing Clinical Trials Differently?Semantic proximity
The Current Landscape of Clinical TrialsSemantic proximity
Select a neighboring publication to make it the new centre.